ON 579
Alternative Names: ON-579Latest Information Update: 10 Nov 2006
At a glance
- Originator Taisho Pharmaceutical
- Class Antiallergics; Anticoagulants; Antiplatelets; Phenoxyacetates; Small molecules; Sulfonamides
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 10 Nov 2006 Discontinued - Preclinical for Asthma in Japan (unspecified route)